Jeffrey Adam Novack - 02 Feb 2026 Form 4 Insider Report for CareDx, Inc. (CDNA)

Signature
/s/ Jeffrey Adam Novack
Issuer symbol
CDNA
Transactions as of
02 Feb 2026
Net transactions value
-$202,820
Form type
4
Filing time
04 Feb 2026, 16:22:20 UTC
Previous filing
05 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Novack Jeffrey Adam Secretary and General Counsel C/O CAREDX, INC., 8000 MARINA BOULEVARD, 4TH FLOOR, BRISBANE /s/ Jeffrey Adam Novack 04 Feb 2026 0002019976

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Award $0 +33,000 +34% $0.000000 130,925 02 Feb 2026 Direct F1
transaction CDNA Common Stock Award $0 +4,342 +3.3% $0.000000 135,267 02 Feb 2026 Direct F2
transaction CDNA Common Stock Tax liability $50,887 -2,492 -1.8% $20.42 132,775 02 Feb 2026 Direct F3
transaction CDNA Common Stock Tax liability $60,647 -2,970 -2.2% $20.42 129,805 02 Feb 2026 Direct F4
transaction CDNA Common Stock Sale $91,286 -4,441 -3.4% $20.56 125,364 03 Feb 2026 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units ("RSUs"), of which one-third will vest on April 6, 2027 and the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each of the subsequent eight quarters, rounded down to the nearest whole share until the last such installment, such that one-hundred percent of the RSUs will be vested on the third anniversary of April 6, 2027, subject to the Reporting Person's continuous employment on each applicable vesting date.
F2 The reported securities were subject to a performance restricted stock unit ("PRSU") award that was initially granted on February 1, 2025, and were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation and Human Capital Committee of the Issuer's Board of Directors on February 2, 2026.
F3 These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of PRSUs.
F4 These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of RSUs.
F5 The transaction reported in this row was effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on September 4, 2025.